Geriatrie et Psychologie Neuropsychiatrie du Vieillissement is a pivotal academic journal dedicated to the multidisciplinary study of aging, encompassing the fields of geriatrics, neuropsychiatry, and psychological health in the elderly population. Published by JOHN LIBBEY EUROTEXT LTD, this journal fosters knowledge dissemination and innovation, contributing to the understanding of the complexities faced by aging individuals. With a broad scope that includes biological psychiatry and neuropsychology, it serves as a vital resource for researchers, healthcare professionals, and students engaged in geriatric medicine and mental health. Although currently classified in the Q4 category across various relevant medical and psychological disciplines, the journal addresses critical topics that are essential for enhancing quality of care and improving patient outcomes. Additionally, the journal is accessible via open access options, promoting wide-ranging readership and collaboration within the academic community. As the field continuously evolves, Geriatrie et Psychologie Neuropsychiatrie du Vieillissement remains commited to pushing the boundaries of research and practice in gerontology and neuropsychiatry.

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

Expert Opinion on Drug Safety is a prestigious academic journal dedicated to advancing knowledge in the fields of drug safety and pharmacology. Published by Taylor & Francis Ltd, this journal serves as an essential resource for researchers and professionals seeking to explore the complexities of drug interactions, adverse effects, and risk management. With an impressive impact factor and recognized as a Q1 journal in both the Medicine (Miscellaneous) and Pharmacology (Medical) categories, it ranks favorably at #78 out of 272 in Scopus, placing it in the 71st percentile among its peers. Operating under a rigorous peer-review process, the journal publishes original research, expert reviews, and opinion pieces that contribute to a deeper understanding of drug safety practices. While not an open access journal, it remains a vital platform for disseminating pivotal findings and fostering scholarly dialogue, ensuring that critical insights reach a global audience. With continuous publication from 2002 to 2024, Expert Opinion on Drug Safety is a key reference for anyone involved in pharmaceutical research, healthcare practice, or drug regulation.

ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, published by SPRINGER HEIDELBERG, is an authoritative journal dedicated to advancing the field of geriatrics and gerontology. With its ISSN 0948-6704 and E-ISSN 1435-1269, this journal has been a significant source of scholarly articles since its inception in 1995, catering to researchers and practitioners amid the growing importance of ageing studies. While it currently holds a Q4 ranking in Geriatrics and Gerontology and a Q3 ranking in Gerontology and Social Sciences, its contribution spans vital topics related to health ethics and legal aspects—reflecting a comprehensive view of the challenges faced in elder care. Although it is not an open-access journal, its rigorous peer-review process ensures that the research published is of high quality and relevance. Based in Heidelberg, Germany, the journal aims to foster discourse and disseminate crucial research findings that impact the health of elderly populations, making it an essential resource for researchers, healthcare professionals, and students devoted to improving geriatric care and understanding the complexities associated with ageing.

Geriatrics is a leading academic journal committed to advancing the understanding and research within the expansive field of gerontology and geriatric medicine. Published by MDPI since 2016 and featuring an Open Access model, this journal aims to disseminate high-quality research that addresses the challenges and opportunities associated with aging populations. Based in Switzerland, Geriatrics has rapidly gained recognition, achieving notable rankings in various categories such as Q2 in Gerontology and Q3 in both Aging and Geriatrics and Gerontology, making its contributions significant within the scholarly community. The journal welcomes original articles, reviews, and case studies, focusing not only on clinical aspects but also on social science perspectives related to health. Researchers and professionals in the field will find this journal a vital resource for the latest insights and trends that are crucial to improving elderly care and enhancing quality of life for aging individuals globally. With its commitment to open access, Geriatrics ensures that crucial research findings are readily available to all stakeholders, thus promoting informed dialogue and collaboration across disciplines.

Aging Medicine and Healthcare is a leading Open Access journal dedicated to advancing the understanding of geriatric health and the complexities of aging. Published by the Asia Pacific League Clinical Gerontology & Geriatrics, this innovative journal began its journey in 2019 and has since established itself as an important resource for healthcare professionals, researchers, and students interested in the fields of geriatrics and gerontology. With an impact factor that reflects its growing significance (ranked in the 21st percentile within its category), the journal aims to disseminate high-quality research and practical insights that can inform clinical practice and enhance patient care for aging populations. As an Open Access publication, it ensures that research findings are freely accessible, fostering collaboration and knowledge sharing among academics and practitioners globally. The journal is poised to be a vital platform for innovative studies, systematic reviews, and case reports that illuminate the challenges and opportunities in aging medicine.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, published by WILEY, serves as a vital resource in the fields of medicine, pharmacology, and toxicology. With an ISSN of 1742-7835 and E-ISSN 1742-7843, this journal has established a robust reputation, reflected in its Q2 classification across its categories in 2023. It aims to disseminate high-quality research and reviews that bridge the gap between basic scientific findings and clinical applications. Operating from the United States with an address at 111 RIVER ST, HOBOKEN 07030-5774, NJ, this journal focuses on the intersection of drug action and toxicity, making it an essential platform for researchers, healthcare professionals, and students. With a converged publication timeline from 2004 to 2024, BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY continues to make significant contributions to understanding pharmacological treatments and toxicological challenges. Open access options are available to broaden the reach and impact of its published work.

Journal of Frailty & Aging, published by SPRINGER BASEL AG, is a leading platform dedicated to advancing research in the fields of aging, geriatrics, and gerontology. With an ISSN of 2260-1341 and an E-ISSN of 2273-4309, this journal has established itself as a pivotal resource for scholars and practitioners aiming to explore the complexities of frailty and its impact on aging populations. As of 2023, it proudly holds a Q3 classification in Aging and Q2 classifications in both Geriatrics and Gerontology, as well as Physiology (medical), alongside a notable Q1 ranking in Medicine (miscellaneous). The journal's Scopus ranks further reflect its quality and relevance, with rankings as high as #22 in Aging within the Biochemistry, Genetics and Molecular Biology category. The Journal of Frailty & Aging invites contributions that illuminate contemporary challenges and innovations in the field, offering Open Access to enhance the dissemination of knowledge. By publishing rigorous research and impactful reviews, the journal strives to foster a deeper understanding of health and well-being in older adults, making it an essential resource for researchers, healthcare professionals, and students engaged in this vital area of study.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, an esteemed publication in the field of pharmacology, is published by Wiley-Hindawi and has been at the forefront of clinical research since its inception in 1976. Operating primarily from the United Kingdom, this journal features a diverse array of articles that encompass both fundamental and practical aspects of clinical pharmacy, thereby supporting the advancement of therapeutic practices. With an ISSN of 0269-4727 and an E-ISSN of 1365-2710, it is indexed in key databases and holds respectable ranks within its categories; achieving Q3 in Pharmacology and Q2 in Medical Pharmacology in the latest quartile rankings. Its Scopus ranking reflects both its quality and relevance, being positioned in the 55th percentile for medical pharmacology and the 45th for pharmacology, toxicology, and pharmaceutics. Although it does not currently operate under an Open Access model, the journal's extensive readership and rigorous peer-review process ensure that the latest research reaches practitioners and academics alike. With a commitment to bridging the gap between pharmacological science and clinical practice, the JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS remains a critical resource for professionals striving to enhance patient outcomes through informed medication management.

Journal of Gerontology and Geriatrics, published by PACINI EDITORE, is a crucial resource for those dedicated to the study of aging and geriatric health. Since its inception in 2016, this journal has aimed to disseminate high-quality research and findings that address the intricate biological, social, and psychological aspects of aging. With ISSN 2499-6564 and E-ISSN 2499-6564, it strives to foster discussions that enhance our understanding of gerontology and geriatrics on a global scale, despite its current positioning in the Q4 quartile of academic rankings. Located in Pisa, Italy, the journal invites contributions from researchers, professionals, and students who are passionate about advancing knowledge in these critical fields. Although it currently does not offer open access, the journal plays a vital role in connecting the community with essential insights that guide both research and practice in geriatric care.